TAIJI GROUP(SH:600129) Zheng Quan Zhi Xing·2025-07-08 10:19Group 1 - The company held its 29th meeting of the 10th Board of Directors on July 7, 2025, with 11 out of 12 directors present, and the meeting was deemed legal and effective [1][2] - The company proposed to change its accounting firm from Tianjian Accounting Firm to Lixin Accounting Firm due to the expiration of the service term, which requires shareholder approval [1][2] - The company plans to supplement its board of directors by nominating Ms. Yu Xingyue, with her term starting from the approval date by the shareholders [2][6] Group 2 - The company intends to simplify its structure by liquidating its indirect subsidiary, Hainan Taiji Pharmaceutical Import and Export Co., Ltd., to focus on its core business [2][3] - The company will acquire 100% equity of Yuncheng Taiji Smart Traditional Chinese Medicine Co., Ltd. by purchasing shares from its subsidiaries for a nominal price of 1 yuan [3][4] - The company’s subsidiary, Chongqing Fuling Pharmaceutical Factory, will acquire 40% equity of Hainan Taiji Marine Pharmaceutical Co., Ltd. for 2.48 million yuan, increasing its ownership from 60% to 100% [4][5] Group 3 - The company approved the cancellation of the supervisory board and the revision of its articles of association, pending shareholder approval [5][6] - The company revised several governance documents, including the rules for shareholder meetings and board meetings, which will also be submitted for shareholder approval [5][6] - The company announced the convening of its second extraordinary general meeting of shareholders in 2025 [5][6]